ICON plc
Full-service clinical research organization supporting drug development from early phase through post-marketing.
ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs. Headquartered in Dublin, Ireland.
Phases
Indications / Therapeutic Areas
Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Clinical Trial Services
- Clinical Imaging Core Lab
- Central Laboratory Services
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Pharmacovigilance & Drug Safety
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Flow Cytometry Services
- Bioanalysis
- Translational Research
- Biomarker Assays
- Immunogenicity Assays (ADA / NAb)
- Ligand-Binding Bioanalysis (Large Molecule)
- LC-MS Bioanalysis (Small Molecule)
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services
- Oncology Specialty Services
- Immunology & Inflammation Services
- Companion Diagnostics Development
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
Modalities
Technical specifications & accreditations
About this organization
ICON plc is a clinical research organization (CRO) offering comprehensive contract services to pharmaceutical, biotech, medical device, and government clients. Services span the full clinical trial lifecycle:
Clinical Solutions:
- Blended solutions tailored to sponsor challenges
- Decentralized clinical trials and in-home services
- Cardiac safety solutions (ECG, event monitoring, Holter, ECHO, MUGA)
- Medical imaging services
- Site and patient solutions with recruitment and real-world data capabilities
- Early clinical and bioanalytical solutions
Specialized Services:
- Manufacturing and pharmacy services (small batch formulation, labeling, distribution)
- Specialty laboratory solutions for precision medicine and diagnostic co-development
- Outcome measures identification and implementation
- Medical writing and language services
- Regulatory affairs consulting
- Real-world solutions and data analytics (Symphony Health)
Therapeutic Expertise: ICON serves multiple therapeutic areas including cardiovascular, CNS, oncology, infectious diseases, immunology, endocrine/metabolic, hepatology, critical care, rare/orphan diseases, vaccines, cell and gene therapies, biosimilars, medical devices, and pediatrics. The organization notes it has contributed to over 60 FDA/EMA approved therapies in oncology and cell/gene therapy in the last 5 years.
Technology & Innovation: Orbis is ICON's multi-agent platform connecting human expertise, data, and AI across the clinical trial lifecycle. EngageAI provides voice-of-customer feedback enhanced with AI capabilities.
Locations
Headquarters
Dublin · Ireland
Belgium
Belgium · Belgium
Bulgaria
Bulgaria · Bulgaria
Germany
Germany · Germany
Hungary
Hungary · Hungary
Italy
Italy · Italy
Netherlands
Netherlands · Netherlands
Poland
Poland · Poland
Romania
Romania · Romania
Slovakia
Slovakia · Slovakia
South Africa
South Africa · South Africa
Spain
Spain · Spain
Türkiye
Türkiye · Türkiye
United Kingdom
United Kingdom · United Kingdom
Australia
Australia · Australia
China
China · China
India
India · India
Japan
Japan · Japan
Korea
Korea · Korea
Malaysia
Malaysia · Malaysia
Taiwan
Taiwan · Taiwan
Argentina
Argentina · Argentina
Brazil
Brazil · Brazil
Chile
Chile · Chile
Colombia
Colombia · Colombia
Mexico
Mexico · Mexico
Belgium
Belgium · Belgium
Bulgaria
Bulgaria · Bulgaria
Germany
Germany · Germany
Hungary
Hungary · Hungary
Italy
Italy · Italy
Netherlands
Netherlands · Netherlands
Poland
Poland · Poland
Romania
Romania · Romania
Slovakia
Slovakia · Slovakia
South Africa
South Africa · South Africa
Spain
Spain · Spain
Türkiye
Türkiye · Türkiye
United Kingdom
United Kingdom · United Kingdom
Australia
Australia · Australia
China
China · China
India
India · India
Japan
Japan · Japan
Korea
Korea · Korea
Malaysia
Malaysia · Malaysia
Taiwan
Taiwan · Taiwan
Argentina
Argentina · Argentina
Brazil
Brazil · Brazil
Chile
Chile · Chile
Colombia
Colombia · Colombia
Mexico
Mexico · Mexico
United States
United States · United States
Related companies
Similar profiles by shared services, phases, and indications.
IQVIA- Phase I Clinical Trials
- Phase II Clinical Trials
PPD- Phase II Clinical Trials
- Phase III Clinical Trials
Medpace- Phase I Clinical Trials
- Phase II Clinical Trials
Fortrea- Phase I Clinical Trials
- Phase II Clinical Trials
Syneos Health- Phase I Clinical Trials
- Phase II Clinical Trials
Novotech- Phase I Clinical Trials
- Phase II Clinical Trials
Tigermed- Phase I Clinical Trials
- Phase II Clinical Trials
Labcorp- Phase I Clinical Trials
- Phase II Clinical Trials
Submit a verified review for this organization.
Former names & acquisitions
ICON plc may also be known by these former brand names or acquired organizations.
ICON
Legacy brand; profile merged after website redirect during enrichment.
Former domain: kcrcro.com
Markdown mirror: /companies/iconplc.md